DENTSPLY SIRONA

Dentsply Sirona, Inc. engages in the design, manufacture, sales and distribution of professional dental products and technologies. It operates through the following segments: Technologies and Equipment and Consumables. The Technologies and Equipment segments comprises dental technology, equipment and healthcare consumable products such as dental implants, laboratory dental products, computer-aided design and computer-aided manufacturing systems, imaging systems, treatment centers and consumable medical device products. The Consumables segment offers preventive, restorative, instruments, endodontic and orthodontic dental products. The company was founded in 1899 and is headquartered in Charlotte, NC.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Dentsply Sirona (XRAY) exceeds Q4 expectations, focuses on innovation

Dentsply Sirona (XRAY) reported strong financial performance in Q4 2022, with a strategic focus on digitalization and innovation. Despite challenges in organic sales and supply chain constraints, the company aims for margin improvement and growth opportunities through investments and pricing strategies. Restructuring efforts and acquisitions are set to drive profitability and market share gains.

Dentsply Sirona reports robust Q1 growth, eyes digital innovation

Dentsply Sirona's strong Q1 performance driven by Consumables and Aligners segments.
Challenges include mixed regional performance and cautious outlook on equipment demand.
Opportunities lie in digitalization, DSO partnerships, and growth in China and EPS targets.
Overall, a positive outlook with strategic focus on innovation and customer experience.

Dentsply Sirona exceeds Q2 expectations, eyes growth amid challenges

Dentsply Sirona reported strong financial performance in Q2 2023, exceeding expectations and raising full-year outlook across key financial metrics.
The company's strategic focus on growth, profitability, and digitalization, coupled with investments in key regions and product innovation, positions it for sustained success.
While facing challenges in certain markets and operational areas, Dentsply Sirona remains optimistic about opportunities for growth, innovation, and value creation in the dental industry.
Overall, Dentsply Sirona's performance highlights operational strengths, market positioning, and a forward-looking approach to driving shareholder value and market expansion.

DENTSPLY SIRONA reports mixed Q3 results, focuses on innovation and growth

DENTSPLY SIRONA's Q3 performance showed mixed results with challenges in certain markets but strength in key segments like CAD/CAM and Aligners.
The company is focused on driving value through innovation, maintaining a commitment to long-term plans, and navigating external challenges with confidence.
Despite headwinds, DENTSPLY SIRONA remains within guidance range for the year, with a strategic focus on volume growth and market expansion opportunities.

DENTSPLY SIRONA anticipates double-digit EPS growth in 2024

DENTSPLY SIRONA's Q4 2023 performance showed growth in key segments, with strategic initiatives set for 2024 as an inflection year for double-digit EPS growth.
The company is focusing on innovation, SKU optimization, and operational efficiency to drive profitability and revenue growth.
Challenges lie in certain segments and the need for organic growth normalization by 2025, but opportunities exist in new product launches and margin expansion.
Overall, DENTSPLY SIRONA is poised for accelerated profitable growth, with 2024 expected to be a pivotal year for improved performance.

DENTSPLY SIRONA reports mixed Q1 performance amidst innovation focus

DENTSPLY SIRONA navigated challenges in Q1 with a focus on innovation, sustainability, and strategic updates. While facing headwinds in certain segments and markets, the company aims to capitalize on growth opportunities through product launches and strategic initiatives.

DENTSPLY Sirona navigates revenue decline with strategic restructuring plans

DENTSPLY Sirona's Q2 performance reflects revenue decline and margin contraction, prompting strategic restructuring and focus on customer-centric initiatives. While facing challenges from macroeconomic factors and restructuring impacts, the company aims to leverage opportunities in shareholder returns and market dynamics to drive growth and operational efficiency.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Dentsply Sirona, Inc. engages in the design, manufacture, sales and distribution of professional dental products and technologies. It operates through the following segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The Connected Technology Solutions segment is engaged in designing, manufacturing, and selling dental technology and equipment products. The Essential Dental Solutions segment designs, manufactures, and sells value-added endodontic, restorative, and preventive consumable products. The Orthodontic and Implant Solutions segment designs, manufactures, and sells various digital implant systems and dental implant products. The Wellspect Healthcare segment designs, manufactures, and sells continence care solutions for management of both urinary and bowel dysfunction dental products. The company was founded in 1899 and is headquartered in Charlotte, NC.

CHARLOTTE, N.C., Dec.  11, 2019  (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona”) (NASDAQ: XRAY), The Dental Solutions Company™, announced that its Board of Directors declared a quarterly cash dividend of $0.10 per share of common stock, an indicated annual rate of $0.40 per share.  The dividend is payable on January 10, 2020 to holders of record on December 27, 2019.

Dentsply Sirona  Declares Quarterly Cash Dividend

Align Technology

XRAY vs. ALGN: Which Stock Is the Better Value Option?

XRAY or ALGN: Which Is the Better Value Stock Right Now?

Dentsply (XRAY) reported earnings 30 days ago. What's next for the stock?

Why Is Dentsply (XRAY) Up 1.7% Since Last Earnings Report?

Growth in the orthodontics market has been primarily led by rising focus of vendors on emerging markets, such as Asia-Pacific and LAMEA.

3 Orthodontic Stocks to Keep an Eye On

Biogen

Celgene

DaVita

Edwards Lifesciences

HCA Healthcare

Incyte

Pfizer

Teleflex

Health Care Select Sector SPDR Fund

These are the health care stocks with the best value, fastest growth, and most momentum for November.

Top Health Care Stocks for November 2019

DENTSPLY SIRONA Inc. (XRAY) CEO Donald Casey on Q3 2019 Results - Earnings Call Transcript

DENTSPLY SIRONA (XRAY) gains from solid segmental contributions in Q3.

DENTSPLY SIRONA (XRAY) Beats on Q3 Earnings, Ups '19 View

Dentsply (XRAY) delivered earnings and revenue surprises of 14.00% and 1.82%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?

Dentsply International (XRAY) Beats Q3 Earnings and Revenue Estimates

AmerisourceBergen

Abbott Labs

Cardinal Health

Penumbra

Varian Medical Systems

Despite the ongoing US-China trade war, solid growth in emerging markets is likely to have contributed to the performance of the players in the medical products space this earnings season.

Medical Products' Nov 7 Earnings Roster: ABC, CAH & More

West Pharmaceutical Services

XRAY vs. WST: Which Stock Is the Better Value Option?

XRAY or WST: Which Is the Better Value Stock Right Now?

Dentsply (XRAY) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Why Dentsply (XRAY) is Poised to Beat Earnings Estimates Again

NVIDIA

Tyson Foods

Stock charts of NVDA, XRAY and TSN are set to start the new trading week on the verge of key moves.
The post 3 Big Stock Charts for Monday: Tyson Foods, Nvidia and Dentsply Sirona appeared first on InvestorPlace.

3 Big Stock Charts for Monday: Tyson Foods, Nvidia and Dentsply Sirona

CHARLOTTE, N.C., Sept.  25, 2019  (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona”) (Nasdaq: XRAY), the Dental Solutions Company, today announced that Janet S. Vergis has been appointed to its Board of Directors, increasing the size of its Board from ten to eleven members.

Dentsply Sirona Announces Appointment of Janet Vergis as New Board Member

Henry Schein

Patterson Companies

Dental practice management software helps dental businesses run smoothly by ensuring safe storage and easy access of critical information.

3 Best Dental Stocks to Keep An Eye On

Dentsply (XRAY) Down 2.3% Since Last Earnings Report: Can It Rebound?

CHARLOTTE, N.C., Aug.  30, 2019  (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona”) (Nasdaq: XRAY), the Dental Solutions Company, today announced that it will participate in the 2019 Baird Global Healthcare Conference on September 4th in New York City. 

Dentsply Sirona to Present at the 2019 Baird Global Healthcare Conference on September 4th

Cerner

Cognizant Technology Solutions

Microsoft

Former U.S. Vice President Al Gore (Trades, Portfolio), leader of Generation Investment Management, and Parnassus Investments’ Jerome Dodson (Trades, Portfolio) may take slightly different approaches to identifying good value opportunities, but they are both known for their commitment to being socially responsible.

5 Stocks These Socially Responsible Gurus Agree On

DENTSPLY SIRONA Inc. (XRAY) CEO Donald Casey on Q2 2019 Results - Earnings Call Transcript

The dental solutions provider didn't meet analysts' revenue expectations in Q2 but achieved significant bottom-line improvement.

Dentsply Sirona Ups Its Full-Year Outlook After Beating Q2 Earnings Estimates

DENTSPLY SIRONA (XRAY) raises guidance for 2019 adjusted EPS.

DENTSPLY SIRONA (XRAY) Q2 Earnings Beat, Revenues Fall Y/Y

Dentsply (XRAY) delivered earnings and revenue surprises of 6.45% and -2.45%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?

Dentsply International (XRAY) Q2 Earnings Top Estimates

Dentsply Sirona (XRAY) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

Why Earnings Season Could Be Great for Dentsply Sirona (XRAY)

Why Dentsply (XRAY) Could Beat Earnings Estimates Again

Copa Hlds

Helix Energy Solutions Group

John Bean Technologies

Lockheed Martin

M.D.C. Holdings

RenaissanceRe Hlds

Here we pick seven stocks that have outperformed the S&P 500 and are likely to beat earnings estimates this reporting cycle.

7 S&P 500-Beating Stocks to Buy Ahead of Q2 Earnings

Dental products maker Dentsply Sirona Inc. said Monday it has appointed Jorge Gomez, former chief financial officer of Cardinal Health Inc.

News for DENTSPLY SIRONA Stock (XRAY)